Mirati Therapeutics, Inc. ( MRTX) - Stock Earnings

MRTX Quarterly earnings

DateEarningsRevenue
2022Q2 -176.4 million USD 5.4 million USD
2022Q3 -173.6 million USD 5.4 million USD
2022Q4 -202.5 million USD 934000 USD

MRTX Yearly earnings

DateEarningsRevenue
2020 -357.9 million USD 13.4 million USD
2021 -581.8 million USD 72.1 million USD
2022 -740.9 million USD 12.4 million USD

MRTX

Price: $58.70

52 week price:
27.30
64.41

Earnings Per Share: -12.18 USD

P/E Ratio: -4.71

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 933700

Ebitda: -16.6 million

Market Capitalization: 4.2 billion

Links: